Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

  1. Facon, T.
  2. Niesvizky, R.
  3. Mateos, M.-V.
  4. Siegel, D.
  5. Rosenbaum, C.
  6. Bringhen, S.
  7. Weisel, K.
  8. Joy Ho, P.
  9. Ludwig, H.
  10. Kumar, S.
  11. Wang, K.
  12. Obreja, M.
  13. Yang, Z.
  14. Klippel, Z.
  15. Mezzi, K.
  16. Goldrick, A.
  17. Tekle, C.
  18. Dimopoulos, M.A.
Aldizkaria:
Blood Advances

ISSN: 2473-9537,  2473-9529

Argitalpen urtea: 2020

Alea: 4

Zenbakia: 21

Orrialdeak: 5449-5459

Mota: Artikulua

DOI: 10.1182/BLOODADVANCES.2020001965 GOOGLE SCHOLAR lock_openSarbide irekia editor